Tramadol hydrochloride
Eugene Melnyk, Chairman of the Board and Chief Executive Officer commented, The filing of Ralivia FlashDose is very significant, complementing our filing of Ralivia ER and marking our development Tramadol hydrochloride of a franchise of pain medications. The combined market for narcotic tramadol hydrochloride and non-narcotic analgesics generated sales of $13. 9 billion in the United States for this same time period. Under this alliance, Janssen will carry out further development in the field of non-cancer pain. Copies of this and other news releases may be Tramadol hydrochloride obtained free of charge from IVAX’ web site at http://www. Over 80% of Teva’s sales are in North America and Europe. Safe Harbor Statement: under the U. Biovail has submitted a new drug application to the FDA for Ralivia FlashDose an orally disintegrating tablet version of the analgesic medication tramadol hydrochloride for the treatment of moderate to moderately severe pain. Biovail will manufacture, supply and sell Ultram(R) ODT to Ortho-McNeil for distribution at prices approximately equal to 30% of Ortho-McNeil’s net selling price. In either field, Nippon Shinyaku and Janssen will jointly file a new drug application and market it separately under their own trade names. TORONTO — Biovail Corporation (NYSE:BVF)(TSX:BVF) today announced that it has received an Approval Letter from the United States Food & Drug Administration (FDA) for Tramadol ODT (tramadol hydrochloride), an orally disintegrating tablet version of the analgesic medication tramadol hydrochloride in 50mg dosage format, intended for the treatment of moderate to moderately severe pain in adults. Biovail will develop a timeline for presenting this extensive clinical data set after determining whether Biovail will launch Ralivia ER(TM) through its own sales force in the United States or Tramadol hydrochloride outlicense it to a partner. Teva’s product is approved for the management of moderate to moderately severe pain. Important factors that could cause or contribute to such regulatory environment and changes in the health policies and structure of various countries, acceptance and demand for new pharmaceutical products and new therapies, the impact of competitive products and pricing, the availability and pricing of ingredients used in the manufacture of pharmaceutical products, uncertainties regarding market acceptance of innovative products newly launched, currently being sold or in development, the impact of restructuring of clients, reliance on a strategy of acquiring companies and on strategic alliances, exposure to product liability claims, dependence on patent and other protections for our innovative products, fluctuations in currency, exchange tramadol hydrochloride and interest rates, operating results, and other factors that are discussed in the Company’s Annual Report on Form 20-F and the Company’s other filings with the U. Tramadol is currently sold in the United States under the brand name Ultram(R) with approximately 11 million prescriptions dispensed during for the twelve months ended December 31, 2003 including generics. Since March 2001, Able has received 14 ANDA approvals. Food and Drug Administration and Canadian Therapeutic Products Directorate approvals, acceptance and demand for new pharmaceutical products, the impact of competitive products and pricing, new product development and launch, reliance on key strategic alliances, tax rate assumptions, availability of raw materials and finished products, the regulatory environment, the outcome of legal proceedings, fluctuations in operating results and other risks detailed from time to time in the Company’s filings with the Securities and Exchange Commission and the Ontario Securities Commission. Fluoxetine is tramadol hydrochloride the generic form of Eli Lilly’s antidepressant Prozac. Ultram(R) ODT, which is indicated for moderate to moderately severe pain, received FDA approval in May tramadol hydrochloride 2005, and will be available in a 50mg dosage strength. Forward-looking statements are identified by words such as "believe", "anticipate", "expect", "intend", "plan", "will", "may" and other similar expressions.